NEXT Houston

Running trials

• Recruiting

  A Phase I/II, First-in-Human Study to Evaluate TJ102 in Participants With Advanced or Metastatic Ovarian Cancer and Other Solid Tumors.

  NCT07778498· Phase 1/2· Source

• Recruiting

  A Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal Cancer

  NCT07693751· Phase 1/2· Source

• Recruiting

  Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

  NCT07524322· Phase 1· Source

• Recruiting

  A Study in Patients With Metastatic Castration-Resistant Prostate Cancer

  NCT07719361· Phase 1· Source

• Recruiting

  A First in Human Study of PLT012 in Participants With Solid Tumor Cancers

  NCT07337525· Phase 1· Source

• Recruiting

  Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer

  NCT07315113· Phase 1· Source

• Recruiting

  STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas

  NCT06975293· Phase 1/2· Source

• Recruiting

  Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

  NCT07080242· Phase 1· Source

• Recruiting

  A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

  NCT06270706· Phase 1· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer3 recruiting
• Lung cancer3 recruiting
• Bladder cancer2 recruiting
• Endometrial cancer2 recruiting
• Liver and biliary tract cancer2 recruiting
• Ovarian cancer2 recruiting
• Prostate cancer2 recruiting
• Cervical cancer1 recruiting
• Kidney cancer1 recruiting
• Melanoma1 recruiting
• Metastatic breast cancer1 recruiting
• Neuroendocrine tumours1 recruiting
• Sarcoma1 recruiting
• Triple-negative breast cancer1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies

  NCT05753722· Phase 1· Source